Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2012
11/15/2012CA2835294A1 Methods of treating or preventing cholesterol related disorders
11/15/2012CA2835258A1 Molecule for treating an inflammatory disorder
11/15/2012CA2835203A1 Compositions and methods for treating cancer
11/15/2012CA2835200A1 C-kit antibodies and uses thereof
11/15/2012CA2835191A1 Hydrophobic preparations
11/15/2012CA2835070A1 Recombinant immunotoxin targeting mesothelin
11/15/2012CA2834956A1 Recombinant vaccine against prrs in a viral vector
11/15/2012CA2834621A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
11/15/2012CA2833554A1 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
11/14/2012EP2522727A1 Highly functional bispecific antibody
11/14/2012EP2522724A1 Polypeptide modification method for purifying polypeptide multimers
11/14/2012EP2522719A1 Influenza hemagglutinin and neuraminidase variants
11/14/2012EP2522678A1 Neutralizing antibodies to influenza viruses
11/14/2012EP2522364A1 Method of treating hemolytic disease
11/14/2012EP2522363A1 Method of treating hemolytic disease
11/14/2012EP2522362A1 Method of treating hemolytic disease
11/14/2012EP2522361A1 Method of treating hemolytic disease
11/14/2012EP2522360A1 Vaccine for treatment of tautopathy
11/14/2012EP2521786A2 Compositions and methods for vaccinating against hsv-2
11/14/2012EP2521733A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
11/14/2012EP2521568A2 Plasma kallikrein binding proteins
11/14/2012EP2521567A1 Administration route for a composition to protect an animal against rhodococcus equi
11/14/2012EP2521563A2 Methods and compositions for providing protective immunity in the elderly
11/14/2012EP2521539A2 Injectable formulations for parenteral administration
11/14/2012EP2521536A2 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
11/14/2012EP1707627B1 Antagonistic anti-CD40 antibody mutant
11/14/2012CN1717417B Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN1338947B Novel mucosal delivery system
11/14/2012CN102782138A Vaccines comprising heat-sensitive transgenes
11/14/2012CN102782136A Vectors expressing HIV antigens and GM-CSF and related methods for generating an immune response
11/14/2012CN102782129A Pharmaceutical composition
11/14/2012CN102781964A Anti-CDH3 antibodies and uses thereof
11/14/2012CN102781962A Biparatopic A-beta binding polypeptides
11/14/2012CN102781961A Hepatitis B virus specific antibody and uses thereof
11/14/2012CN102781958A Malaria vaccines based on apicomplexan Ferlins, Ferlin-like proteins and other C2-domain containing proteins
11/14/2012CN102781954A A cytolytic RTX-toxin from gallibacterium anatis
11/14/2012CN102781517A Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus
11/14/2012CN102781472A Radiation therapy agent
11/14/2012CN102781471A Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation
11/14/2012CN102781470A Il-17 binding proteins
11/14/2012CN102781469A Process for producing influenza vaccine
11/14/2012CN102781468A Method for the identification of animals vaccinated against brucella
11/14/2012CN102781467A Treatment of nasal and sinus disorders
11/14/2012CN102781466A Probiotic bifidobacterial composition in accordance with secretor blood group status ?
11/14/2012CN102781465A Composition for treatment of multiple sclerosis
11/14/2012CN102781456A Mycobacterium mutants for vaccines with improved protective efficacy
11/14/2012CN102778566A Application of DLK1 in diagnosis and prognosis of liver cancer
11/14/2012CN102776155A Chinese isolated strain of bovine enterovirus, and construction and application of infectious cDNA clone thereof
11/14/2012CN102776134A Streptococcus suis Serotype 2 (SS2 for short) double-gene deleted live vaccine and its application
11/14/2012CN102775501A Interleukin 21 (IL-21) medicine for cancer therapy
11/14/2012CN102775495A Polypeptide mixture, T cell vaccine and application thereof
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102775478A Foot and mouth disease virus antigen peptide and vaccine
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775470A Short peptide for inhibiting human hepatitis B virus infection and its application
11/14/2012CN102775469A Antigen epitope of influenza A virus nucleocapsid protein, and its use
11/14/2012CN102772799A Duplex egg yolk antibody freeze-drying powder for duck virus hepatitis and duck plague and preparation method thereof
11/14/2012CN102772798A Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds
11/14/2012CN102772797A Genetic engineering polypeptide vaccine for 4 subtypes of O-type foot and mouth disease virus and its application
11/14/2012CN102772796A Genetic engineering polypeptide vaccine for Myanmar subtype-containing 3 subtypes in O-type foot and mouth disease virus, its preparation and application
11/14/2012CN102772795A Application of brucella flagellin BME II 1112 in preparation of brucella subunit vaccines
11/14/2012CN102772794A Application of brucellosis A19 molecular marking vaccine and immunological identification thereof
11/14/2012CN102772793A Brucella deoxyribonucleic acid (DNA) vaccine as well as construction method and application thereof
11/14/2012CN102772792A Vaccine for preventing decayed tooth and preparation method thereof
11/14/2012CN102772791A Tumor vaccine and preparation method thereof
11/14/2012CN102260649B Infectious bursal disease virus (IBDV) and method for preparing inactivated vaccines and combined vaccines by breeding IBDV with chick-embryo cell system and bioreactor
11/14/2012CN102242122B Nucleic acid aptamer specifically combined with HCV (hepatitis C virus) non-structural protein NS2, and application thereof
11/14/2012CN102127524B Method for proliferating avian influenza viruses in bioreactor with cell carrier
11/14/2012CN102060911B Polypeptide combined with various amyloid protein monomers simultaneously and application thereof
11/14/2012CN101912604B Preparation method of live vector vaccine for controlling chicken coccidiosis and application thereof
11/14/2012CN101886123B Application of vascular endothelial growth factor receptor-2 (VEGFR-2) in temporomandibular joint disturbance
11/14/2012CN101864398B Monoclonal antibody of anti-gonadotropin-releasing hormone receptor and application thereof
11/14/2012CN101845083B Synthetic peptide vaccine for treating porcine reproductive and respiratory syndrome and preparation method thereof
11/14/2012CN101747416B B-cell antigenic multi-epitope peptide linked in tandem in OmpU of vibrio mimicus, making method and application thereof
11/14/2012CN101679518B The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
11/14/2012CN101636174B Method for producing a tumor vaccine
11/14/2012CN101618212B Gene vaccine of tuberculosis multivalence epitope and application thereof
11/14/2012CN101445802B Novel porcine circovirus virus, vaccines and diagnosis agent
11/14/2012CN101330928B Immunostimulatory combination for the prophylactics and treatment of hepatitis c
11/14/2012CN101312737B Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer
11/14/2012CN101287475B Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
11/14/2012CN101164623B Methods for concentrating virus preparations
11/14/2012CN101080487B Mature dendritic cell compositions and methods for culturing same
11/14/2012CN101065146B Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
11/13/2012US8309702 Primers for detecting Plasmodium
11/13/2012US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/13/2012US8309692 Antibodies to cytokine receptor ZCYTOR17
11/13/2012US8309527 For use as antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics
11/13/2012US8309327 Method of producing an immunogenic composition
11/13/2012US8309326 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
11/13/2012US8309102 Methods and compositions for immunizing against Chlamydia infection
11/13/2012US8309101 Pasteurella multocida vaccine
11/13/2012US8309100 Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains
11/13/2012US8309099 DNA transfection system for the generation of negative strand RNA virus
11/13/2012US8309098 Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)
11/13/2012US8309097 C-type lectin binding molecules, identification and uses thereof
11/13/2012US8309096 Fusion protein
11/13/2012US8309095 Parathyroid hormone receptor activation and stem and progenitor cell expansion
11/13/2012US8309094 Antibody-drug conjugates
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 1823